Beranda › Glioma › North Carolina › Durham
Uji klinis Glioma di Durham, NC
12 studi untuk Glioma mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Menerima pesertaFase 2
- Duke University Medical Center, Durham
Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- Duke Cancer Institute, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Menerima pesertaFase 1
- Duke University Medical Center, Durham
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Menerima pesertaFase 2
- Duke Cancer Center, Durham
Lerapolturev (PVSRIPO) in GBM
Menerima pesertaFase 2
- Duke University Medical Center, Durham
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Menerima pesertaFase awal 1Sukarelawan sehat diterima
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Menerima pesertaFase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Menerima pesertaFase 2
- Duke University Health System, Durham
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Menerima pesertaFase 1
- Duke University, Durham
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Menerima pesertaFase awal 1
- Duke University Health System, Durham
Uji klinis Glioma di kota lain
- New York City, NY25 studi
- Houston, TX23 studi
- Boston, MA20 studi
- Washington, DC19 studi
- Philadelphia, PA16 studi
- Columbus, OH15 studi
- Miami, FL15 studi
- San Francisco, CA14 studi
- Chicago, IL13 studi
- Seattle, WA11 studi
- Los Angeles, CA10 studi
- St. Louis, MO10 studi
Studi lain di Durham
- Kanker Payudara63 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Kanker Metastatik33 studi
- Leukemia Mieloid Akut33 studi
- Kanker Paru32 studi
- Kanker Prostat32 studi
- Kanker Kolorektal28 studi
- Leukemia Limfositik Kronis27 studi
- Kanker Ovarium27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.